Musk's Neuralink Enters Human Trials

Neuralink, a neurotech company co-founded by Elon Musk, has received FDA approval to conduct its inaugural human clinical trial. The company is working on a brain-computer interface named the Link, to help severely paralyzed patients manipulate external technologies using neural signals. This could allow individuals suffering from diseases like ALS to regain communication abilities. The details of the approved trial are not yet known, but this approval marks a significant milestone for Neuralink. The company's technology, which involves invasive brain surgery to implant the Link device, has faced recent controversy over alleged unsafe hardware practices and unethical animal testing.